CompletedNo phase
Long-term Observation of PAP-therapy With Telemonitoring: Telemedicine Registry TelePAP
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
Trial details
- Who runs it
- ResMed
- Trial code
- NCT03043716
- Record updated
- 17 August 2026
- Original description
Telemonitoring for Positive Airway Pressure (PAP) therapy might help to establish and maintain long-term therapy adherence and thus support the beneficial effects of PAP therapy on long-term outcomes.Read full original descriptionShow less
Long-term Observation of Adherence and Efficacy of Patients With a Positive Airway Pressure (PAP) Therapy With Use of Telemonitoring
Telemonitoring for Positive Airway Pressure (PAP) therapy might help to establish and maintain long-term therapy adherence and thus support the beneficial effects of PAP therapy on long-term outcomes.
Inclusion: Patients older than 18 years; New indication for a prescription of a Telemonitoring (AirViewTM)-capable ResMed PAP-device; Consent to use the telemonitoring System AirViewTM (ResMed GmbH \& Co KG); Signed Informed Consent.
Exclusion: Pregnant and breastfeeding persons.